Keyphrases
Inflammatory Bowel Disease
100%
Crohn's Disease
62%
Crohn's
55%
Colitis
35%
Small Molecule Therapy
33%
Gastroenterologist
33%
American College of Gastroenterology
33%
2-dose
33%
Serrated Epithelial Change
33%
Small Bowel Crohn's Disease
33%
Antibody Response
33%
Enteritis
33%
Neoplasia
33%
Small Intestine
33%
Case-controlled Study
33%
Pregnancy Outcome
33%
Diagnostic Codes
33%
Policy Outcomes
33%
SARS-CoV-2 mRNA Vaccination
33%
Ulcerative Colitis Patient
33%
Electrical Neuromodulation
33%
Infliximab
33%
Systematic Meta-analysis
33%
Ipilimumab
33%
ICD-9
33%
Parental Leave Policy
33%
Family Leave Policies
33%
Adalimumab
33%
Perianal Fistula
33%
Positive Predictive Value
26%
Anti-tumor Necrosis Factor (anti-TNF)
24%
Small Bowel Disease
22%
First-line Therapy
22%
Upadacitinib
22%
Ulcerative Colitis
18%
Safety in Pregnancy
16%
Effective Therapy
14%
High Risk
13%
Non-white
13%
Domain Antibody
13%
Fistula Repair
13%
Ligand-binding Domain
13%
Crohn's Colitis
13%
Antireceptor
13%
Extraintestinal Manifestations
13%
Janus Kinase Inhibitors
11%
Parenting
11%
Moderate to Severe
11%
Little Data
11%
Gastroenterology
11%
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Crohn's Disease
85%
Ulcerative Colitis
77%
Patient with Inflammatory Bowel Disease
52%
Combination Therapy
50%
Colitis
38%
Child Parent Relation
33%
Neoplasm
33%
Pregnancy Complication
33%
Adalimumab
33%
Wellbeing
33%
Gastroenterology
33%
Ipilimumab
33%
Diagnosis
33%
Infliximab
33%
Systematic Review with Meta-Analysis
33%
Antibody Response
33%
Anal Fistula
33%
Enteritis
33%
Neuromodulation
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
ICD-9-CM
33%
Colorectal Cancer
23%
Mating Hormone Alpha Factor
22%
Necrosis
22%
Patient with Ulcerative Colitis
19%
Drug Therapy
16%
Logistic Regression Analysis
13%
mRNA Vaccine
11%
COVID-19 Vaccination
11%
Enterocolitis
11%
Monotherapy
11%
Maternal Disease
11%
Immunotherapy
11%
Dysplasia
9%
Adverse Event
9%
Surgical Technique
8%
Patient with Crohn's Disease
8%
Veterans Affairs
8%
Minority Group
8%
Kaplan Meier Method
8%
Metastatic Melanoma
7%
Diarrhea
7%
Symptom
7%
Colonoscopy
7%
Biopsy
7%
Immune-Related Adverse Events
7%
Immunomodulating Agent
6%
Medicine
5%
Randomized Controlled Trial
5%
